Masqueraders: how to identify atypical diabetes in primary care

Area of Science:

• Endocrinology
• Metabolic Diseases

Background:

• Diabetes mellitus affects 34 million Americans, with type 1, type 2, and gestational diabetes being most common.
• Atypical diabetes forms constitute nearly 10% of cases and are often misdiagnosed as type 1 or type 2 diabetes mellitus.
• Misdiagnosis of atypical diabetes can lead to suboptimal treatment strategies.

Purpose of the Study:

• To detail the defining characteristics of various atypical forms of diabetes.
• To demonstrate how these atypical forms can present similarly to type 1 or type 2 diabetes mellitus.
• To improve diagnostic accuracy for less common diabetes presentations.

Main Methods:

• Review and synthesis of clinical characteristics of atypical diabetes subtypes.
• Comparative analysis of presentation patterns for monogenic diabetes (MODY), LADA, ketosis-prone diabetes, and secondary diabetes.
• Discussion of diagnostic challenges and implications for patient management.

Main Results:

• Atypical diabetes forms, including monogenic diabetes (MODY), LADA, ketosis-prone diabetes, and secondary diabetes, present unique clinical features.
• These conditions can mimic the symptoms of type 1 and type 2 diabetes mellitus, complicating diagnosis.
• Accurate identification is essential for tailoring appropriate therapeutic interventions.

Conclusions:

• Healthcare providers must be aware of the diverse spectrum of diabetes mellitus beyond the common types.
• Recognizing the distinct features of atypical diabetes is critical for accurate diagnosis and optimized patient care.
• Further education and diagnostic tools are needed to address the challenges posed by these less familiar diabetes subtypes.